letter

Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)

July 11, 2025 16:30 ET  | Source: Ultragenyx Pharmaceutical Inc. Complete Response Letter (CRL) cited specific chemistry, manufacturing and controls…

2 weeks ago

Prime Success Responds to Sinovac Biotechs False and Misleading Claims

For More Information, Visit www.SaveSinovac.comHONG KONG--(BUSINESS WIRE)--Prime Success L.P., (together with its affiliates, “Prime Success” or “we”), a significant shareholder…

1 month ago

Semilux Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 20-F

June 02, 2025 19:30 ET  | Source: Semilux International Ltd. Taipei, Taiwan, June 02, 2025 (GLOBE NEWSWIRE) -- Semilux International…

2 months ago